Β-CARYOPHYLLENE AS A PARTNER FOR DOXORUBICIN: EVIDENCE FOR CHEMOSENSITISATION, TISSUE PROTECTION AND LIPID-BASED CO-DELIVERY. FMHR. 2026;4(3):4636-4645. Accessed November 9, 2026. https://fmhr.net/index.php/fmhr/article/view/3855